Applications of single-chain variable fragment antibodies in therapeutics and diagnostics
- PMID: 19374944
- DOI: 10.1016/j.biotechadv.2009.04.004
Applications of single-chain variable fragment antibodies in therapeutics and diagnostics
Abstract
Antibodies (Abs) are some of the most powerful tools in therapy and diagnostics and are currently one of the fastest growing classes of therapeutic molecules. Recombinant antibody (rAb) fragments are becoming popular therapeutic alternatives to full length monoclonal Abs since they are smaller, possess different properties that are advantageous in certain medical applications, can be produced more economically and are easily amendable to genetic manipulation. Single-chain variable fragment (scFv) Abs are one of the most popular rAb format as they have been engineered into larger, multivalent, bi-specific and conjugated forms for many clinical applications. This review will show the tremendous versatility and importance of scFv fragments as they provide the basic antigen binding unit for a multitude of engineered Abs for use as human therapeutics and diagnostics.
Similar articles
-
Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.Mol Immunol. 2008 May;45(9):2474-85. doi: 10.1016/j.molimm.2008.01.016. Epub 2008 Mar 3. Mol Immunol. 2008. PMID: 18313757
-
Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragments.Nat Biotechnol. 1996 Oct;14(10):1239-45. doi: 10.1038/nbt1096-1239. Nat Biotechnol. 1996. PMID: 9631086 Review.
-
Helix-stabilized Fv (hsFv) antibody fragments: substituting the constant domains of a Fab fragment for a heterodimeric coiled-coil domain.J Mol Biol. 2001 Sep 7;312(1):221-8. doi: 10.1006/jmbi.2001.4915. J Mol Biol. 2001. PMID: 11545598
-
Different equilibrium stability behavior of ScFv fragments: identification, classification, and improvement by protein engineering.Biochemistry. 1999 Jul 6;38(27):8739-50. doi: 10.1021/bi9902079. Biochemistry. 1999. PMID: 10393549
-
Engineered antibody fragments and the rise of single domains.Nat Biotechnol. 2005 Sep;23(9):1126-36. doi: 10.1038/nbt1142. Nat Biotechnol. 2005. PMID: 16151406 Review.
Cited by
-
Single Chain Variable Fragments Produced in Escherichia coli against Heat-Labile and Heat-Stable Toxins from Enterotoxigenic E. coli.PLoS One. 2015 Jul 8;10(7):e0131484. doi: 10.1371/journal.pone.0131484. eCollection 2015. PLoS One. 2015. PMID: 26154103 Free PMC article.
-
Computational design of a CNT carrier for a high affinity bispecific anti-HER2 antibody based on trastuzumab and pertuzumab Fabs.J Mol Model. 2013 Jul;19(7):2797-810. doi: 10.1007/s00894-012-1638-2. Epub 2012 Nov 10. J Mol Model. 2013. PMID: 23143677
-
Ribosome Display Technology: Applications in Disease Diagnosis and Control.Antibodies (Basel). 2020 Jun 27;9(3):28. doi: 10.3390/antib9030028. Antibodies (Basel). 2020. PMID: 32605027 Free PMC article. Review.
-
Preparation of a Single-Chain Antibody against Nucleocapsid Protein of Porcine Deltacoronavirus by Phage Display Technology.Viruses. 2022 Apr 8;14(4):772. doi: 10.3390/v14040772. Viruses. 2022. PMID: 35458502 Free PMC article.
-
Considerations for the Design of Antibody-Based Therapeutics.J Pharm Sci. 2020 Jan;109(1):74-103. doi: 10.1016/j.xphs.2019.05.031. Epub 2019 Jun 4. J Pharm Sci. 2020. PMID: 31173761 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources